Clinical Trials Browser

Phase 2 × midostaurin × 1 year × Clear all

NCT03591510 2026-03-13

A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03836209 2025-06-15

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

Phase 2 Active not recruiting

181 enrolled 18 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03280030 2025-03-20

A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML

Phase 2 Completed

67 enrolled 21 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute